Untitled Document
Express Press Release Distribution
Home Page
Submit Press Release
EPR Nationwide Sites
Browse By Industries
Search Press Releases
About EPR
Help Pages
Contact Us
Disclaimer
Privacy Policy
Terms of Service
 
 
 
 
Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel
 

EPR Archived News

Archived News 2009
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2008
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2007
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2006
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

 Archived News 2005
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2004
~ December
~ November
~ October
~ September
~ August
~ July

 
 

 

  

Biotech Press Releases

Home - Industries - Biotech Press Releases

Biotech Press Releases

More Biotech News on EPRBiotechNews.com

  • DEFINIENS EXPLORES COMPUTER-AIDED DETECTION APPLICATIONS FOR THE MEDICAL IMAGING MARKET
  • Bio-Synthesis, Inc unveils its latest step into the future of forensic science
  • Biotage Introduces a New Synthesis and Purification Catalog
  • DEFINIENS INTRODUCES DEFINIENS TISSUEMAP 30
  • DYNAPRO DLS PLATE READER FROM WYATT TECHNOLOGY PROVIDES RAPID DETECTION AND CHARACTERIZATION OF PROTEIN AGGREGATES
  • SimGlycan version 2(point)60 released with MS MS annotation support
  • GenScript antibody service guarantees ELISA titer of 1 20000 and positive western blot results
  • AnaSpec Introduces New SensoLyteTM MMP ELISA Kits
  • GenScript Sponsors 12th Annual Healthcare Industry Forum
  • Transgenics Changing the Make-up of Indian Agriculture Industry
  • Film-makers are responsible for Morgellons disease
  • GenScript launches a series of cosmetic peptides
  • AnaSpec Introduces Histone GO(tm) Peptides - Acetylated and Methylated
  • ki work welcomes Martin Blundell as the category leader in twenty five Life Sciences categories
  • Pharmacodynamic PAR ELISA Assay
  • SBS Group Lights The Night for The Leukemia and Lymphoma Society
  • MUNOGENICS INC ANNOUNCES SIGNING FOR WORLDWIDE LICENSING OF `GIFT` GRANULOCYTE INFUSION THERAPY, `CKA` CANCER KILLING ACTIVITY WITH GLOBAL FRANTECH GROUP
  • Ghost in the Machine Podcast Welcomes Authors James Maxey and Adam Roberts
  • A free software hub for the life science community from PREMIER Biosoft
  • Sniffing Out Trouble In Real Time
  • Veeda Clinical Research announces infusion of high-end Data Management backbone
  • TBTA - Click Chemistry Ligand for Cu (I)
  • Biotech Job Market Continues to Remain Strong, Says BiotechCrossing
  • AnaSpec Celebrates 15 Year Anniversary
  • Novozymes Biopharma Announces New Development in Animal-Free Cell Culture Supplements at BioProcess International Conference and Exhibition 2008
  • AnaSpec to Manufacture BD(tm) Fluorescent Dyes for BD Biosciences
  • The One Stop Site for Hair Lovers!
  • AnaSpec Introduces High Performance Labeled Streptavidins
  • RayBiotech and AnaSpec Sign Licensing Agreement for HiLyte(tm) Dyes
  • AnaSpec and Cyclex Sign Licensing Agreement for Deacetylase Activity Assay Kits
  • AnaSpec Introduces Kinase Substrates as GO™ Peptides
  • Impact of Glycomics; Use of Computational Biology in Glycomics Highlighted
  • Recombinant MOG Proteins - NEW
  • Beauty and Health of Natural Collagen Q5-26 Platinum
  • Drug Safety Alliance Adds Pharmaceutical Veteran Deena B Wegner to Management Staff
  • RNCOS Releases a New Report- Asia Pacific Biotechnology Market (2008-2012)
  • AnaSpec Peptides Used in Latest Alzheimer`s Research Findings by VU University Medical Centre and Lund University
  • Accugenix Announces Release of Updated Bacterial Sequence Library 283 new entries continue to grow lab`s impressive DNA sequence database
  • GenScript Corp Offers Additional Discounts to New Laboratories
  • PREMIER Biosoft International, a leading bioinformatics company, successfully completes the third and final phase of its software development project for DxTerity Diagnostics, Inc to support their innovative NEAT technology
  • AnaSpec and UW TechTransfer Sign Licensing Agreement for Protein Tyrosine Phosphatases
  • GenScript Sponsors Fourth Annual Synthetic Biology Convention
  • US demand for biodegradable plastics is predicted to grow nearly 20% annually through 2012
  • GenScript Launches Fluorescent Western Blot Kits Based on the 2nd Generation One-Step Technology
  • Sales of GenScript`s Anti-His Monoclonal Antibody Increase 600 per cent in 2008
  • Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery and Development Summit (Oct 15-17, 2008 – San Diego, CA)
  • Cultrex(r) Mouse Laminin I Now Qualified `PathClear(r)`
  • AnaSpec Introduces Rules 4 and 5 in Truth in Peptides Campaign
  • Ocimum Biosolutions Announces Genomic Pioneer Awards
  • University of British Columbia and AnaSpec Present Poster at ICAD 2008
  • New High Sensitivity Hsp70 ELISA Kit for Serum and Plasma
  • Biocore and AnaSpec Sign Distributor Agreement
  • Isogen Biosolutions BV is now Ocimum Biosolutions B V
  • AnaSpec Introduces GO Peptides(tm) - Research-Ready Peptides On Demand
  • AnaSpec Introduces New SensoLyte(tm) 570 Generic MMP Assay Kit with Industry`s Highest Wavelength
  • GTCBIO ANNOUNCES ITS BIOMARKER DISCOVERY EUROPE CONFERENCE ON OCTOBER 2-3, 2008 IN DUBLIN, IRELAND
  • Bioask -Discovery Inforamtics Suite
  • Indian Biotech Market Gaining Traction from Biopharma
  • Novus Biologicals and AnaSpec Sign Licensing Agreement for HiLyteT Dyes
  • FDA data supports Low Plasticity Burnishing (LPB) as a guardian of metal components
  • AnaSpec Offers Custom Peptide-Aminoluciferin Synthesis
  • Leak-Free PFA Fittings Now Stocked in Twelve Styles; Easy to Install, Disconnect, and Reuse
  • Own a Franchise with Top Notch Dryer Vent Cleaning Company, Dryer Vent Wizard, Dry Clothes, Safe Homes
  • Franchise Opportunity Dryer Vent Wizard, a Dryer Vent Cleaning and Service Company is looking for Franchisees
  • Robert Davie, VP at Covance to Present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Korea`s largest Biotech Show kicks off in Osong
  • Trevigen Announces the First Standardized Comet Assay Electrophoresis System (ES) for Direct Detection of DNA Damage
  • Allium Medical Expands in Europe, Signs Exclusive Distribution Deals in Germany, Austria and Benelux
  • AnaSpec Introduces New Series of PAR Peptides
  • FEECO International Featured in Process Heating Magazine
  • New Anti-Keratin Antibodies Introduced by AnaSpec
  • Let`s Talk Trash in Troy, Michigan—Sherman Rogers of All Waste, LLC Discusses Safety Issues for Trash Haulers and Dumpster Rental Companies
  • All Waste, LLC, Livingston County Dumpster Rental Service Leads the Fight against Breast Cancer
  • All Waste, LLC Leading Dumpster Rental and Roll-off Service in Troy, Michigan
  • All Waste, #1 Washtenaw County, Michigan Waste Management and Dumpster Rental Service works with the Community to remove the Threat of Breast Cancer
  • Dumpster Rental and Waste Management Company in Shelby Twp, Michigan Paints their Dumpsters Pink in Recognition of Breast Cancer Awareness
  • All Waste, LLC, Leading Wayne County Rubbish Removal and Trash Pick-up Service, Helps Cancer Research
  • Sherman Rogers of All Waste, LLC Express Concern for the Liability Risks of Dumpster Diving in Detroit, Michigan Warns Sherman Rogers of All Waste, LLC
  • PMI Announces New CapFlow Machine
  • Anavex Life Sciences Corp will present new findings at the International Conference on Alzheimer`s Disease 2008 (July 26-31, 2008, Chicago, USA)
  • Dumpster Rental, Roll off Dumpster for Residential, Commercial, Industrial for Detroit Metro Area
  • ALL WASTE, LLC 4751 22 Mile Road Shelby Township, MI 48317-1515 Phone 877-524-1002 Fax 586-254-9936 Web site http thegarbagemancom Email sherman@all-wastecom
  • It`s spring clean-up time—All Waste has a variety of dumpsters to serve your needs, no matter how big your project is
  • Dumpster Diving, A new Concern and Risk for Business Owners with Dumpsters in Michigan
  • All Waste joins the battle against breast cancer, supporting those affected by the disease
  • Now Trash Removal is synonymous with the fight to eliminate this disease
  • New SensoLyte HDAC Assay Kit Introduced by AnaSpec
  • AnaSpec Introduces New Anti-SOCS-3 Antibody
  • RNCOS Releases a New Report- Booming Biotech Market in India
  • PharmaEssentia announces milestone in development of new third-generation interferon hepatitis B and C drug candidate
  • Trevigen Announces a Highly Sensitive, Fluorescent, One Hour PARP Inhibition Assay
  • AnaSpec Offers Custom Synthesis of Hydrocarbon-Stapled Peptides
  • Peter Mayne, QA Manager of OSI Pharmaceuticals will Present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Michele Pontinen, Senior Manager of Life Sciences at Capgemini LLC will present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Mark Lanfear, Regional Manager of Kforce-Roche Strategic Alliance at Roche will present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Laurence Flint, Associate Director of Clinical Research at Schering-Plough will present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Larry Blankstein, Senior Director of Clinical Research at Genzyme will present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Kathleen Moran, Vice President of Clinical Operations at Acurian will present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Kathleen Drennan, Senior Vice President and Managing Director of Iris Global Clinical Trial Solutions will present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Helen Niu, Director of Global Development Operations at Amgen will present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Gavin Choy, Vice President of Clinical Research Operations at SuperGen will present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Franco Pasquale, Senior Manager of Manufacturing Collaborations at Genentech will present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Didier Basseras, Senior Director of Global Clinical Packaging Operations at Sanofi Aventis will present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Cosimo Spera from Decision View Company will present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Charlene Dark, Director of Life Sciences at Clarkston Consulting will present at GTCbio`s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA
  • Brahm Goldstein, Director of Clinical Research - Biopharmaceuticals at Novo Nordisk will present at GTCbio`s Global Clinical Trial Operations Conference on September 25-26, 2008 in San Diego, CA
  • Anti-aging Facial Technology Announced by Sunrise Holistic Health Care Practice
  • New Anti-CARMA Antibody Seri
  • Amrit Ray, Vice President of Bristol-Myers Squibb to give Keynote Presentation at GTCbio`s Global Clinical Trial Operations Conference on September 25-26, 2008 in San Diego, CA
  • AnaSpec Introduces Eleven New Peptides
  • Apticraft Systems, the leading bioinformatics software development company, successfully completes the PrimerPlex project
  • Director of Research at BN ImmunoTherapeutics will Present at GTCbio`s 2nd Protein Therapeutics Discovery and Development Conference
  • Ludmilla Morazova-Roche at Umeå University in Sweden to Present at GTCbio`s 2nd Protein Therapeutics Discovery and Development Conference
  • Lab Head at Wyeth Pharmaceuticals to Present at GTCbio`s 2nd Protein Therapeutics Discovery and Development Conference
  • Senior Director of Biotherapeutics at Xencor will Present at GTCbio’s 2nd Protein Therapeutics Discovery and Development Conference
  • Group Leader of Experimental Therapeutics at Celgene to Present at GTCbio`s 2nd Protein Therapeutics Discovery and Development Conference
  • Lino Gonzalez from Genentech to Present at GTCbio`s 2nd Protein Therapeutics Discovery and Development Conference
  • Vice President of Drug Discovery at Phylogica to Present at GTCbio`s 2nd Protein Therapeutics Discovery and Development Conference
  • SVP and Site Head of Pfizer La Jolla to Give Plenary Keynote Address at 4th Modern Drug Discovery and Development Summit
  • Benefect Now buy online
  • Hershey Felder, World`s Largest Online Music Gear Merchant
  • Anavex further strengthens Board of Directors
  • Trevigen announces the release of Four New Assay Kits for 3-D Cell Proliferation
  • New SensoLyte(tm) 520 Cathepsin S Assay Kit Introduced by AnaSpec
  • Bisphenol A Authorities warned of health risk
  • INTAS BIOPHARMA TO MARKET LUNG CANCER DRUG GEFITINIB IN INDIA
  • AnaSpec Introduces Sixty New Peptides and 3 New Assay Kits
  • AnaSpec Introduces 8 New Antibody Products
  • Walter Reed Army Institute of Research (WRI) and Siam Life Science (SLS) Develop New Gold Standard for Pharmacological and Toxicological Test Systems
  • Anavex Announces Appointment of Oncology Specialist to Board of Directors, Changes to Executive Management
  • Trevigen Releases the First Standardized 3-D Culture Cell Harvesting Kit
  • Dog training that is safe for your dog
  • Intas Biopharma expand product presence in MENA region
  • AnaSpec Introduces ClearPoint(tm) Heavy Isotope-Labeled Peptides
  • CRO PREVALERE ANNOUNCES THE OPENING OF AN ADDITIONAL BIOTECH LAB
  • Alpha Synuclein-rPeptide Introduces New proteins
  • AnaSpec`s Published References Passes 600
  • AnaSpec Presents Fluorimetric TACE Detection Poster at SBS Conference
  • PREMIER Biosoft International Releases SimGlycan 251, with Glycopeptide Analysis
  • AnaSpec Introduces a Suite of Phospho-Specific Anti-Her2 Antibodies
  • Bioinformatics Outsourcing for Life Sciences India Opportunity
  • Biotechnology in the European Union; Trends, Investing and Country Profiles
  • Global Biotechnology
  • Asia Pacific Biotechnology Market (2007-2010)
  • 2nd Annual Clinical Trials
  • AnaSpec Introduces Fifty New Catalog Peptides and 1 New Fluorescent Dye
  • Ocimum Biosolutions Launches Genowiz 4, A Comprehensive Gene Expression Analysis Software
  • SensoLyte(tm) MMP Assay Kits Offer a New Industry Standard for Sensitivity
  • AnaSpec FRET-based MMP Substrates Used in Double Differential In Vivo Zymography
  • Can Ozbal,to present at GTCbio`s 3rd Assay Development and Screening Technologies Conference
  • Dr Catherine E Bruederle, to present at GTCbio`s 3rd Assay Development and Screening Technologies Conference
  • Dr Catherine E Bruederle,to present at GTCbio`s 3rd Assay Development and Screening Technologies Conference
  • Cathrin Bruederle to present at GTCbio`s 3rd Assay Development and Screening Technologies Conference
  • Chip Allee, to present at GTCbio`s 3rd Assay Development and Screening Technologies Conference
  • Chip Allee, CEO at CeuticalSoft Inc to present at GTCbio`s 3rd Assay Development and Screening Technologies Conference
  • George Wang, to present at GTCbio`s 3rd Assay Development and Screening Technologies Conference
  • Gary Piazzo, Program Director of the Southern Research Molecular Libraries Screening Center at Southern Research Institute to present at GTCbio`s 3rd Assay Development and Screening Technologies Conference on June 5-6, 2008
  • Anthony Aglione, Associate Principle Scientist at Hoffmann-La Roche to present at GTCbio`s 3rd Assay Development and Screening Technologies Conference
  • Anthony Aglione, Associate Principle Scientist at Hoffmann-La Roche to present at GTCbio`s 3rd Assay Development and Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA
  • Matthew Olson Principle Research Scientist at Johnson and Johnson to Speak at GTCbio`s 3rd Assay Development and Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA
  • New Anti-MMP Antibodies Introduced by AnaSpec
  • Chris Austin, Director of the NIH Chemical Genomics Center to give Keynote Presentation at GTCbio`s 3rd Assay Development and Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA
  • BiomedicalProjectscom is a free website which connects all Biomedical Engineering students to other students, and professionals in the same field throughout the country
  • Hakim Djaballah, Director of HTS at Memorial Sloan Kettering Cancer Center to Present at GTCbio`s 3rd Assay Development and Screening Technologies Conference, June 5-6
  • John Cuozzo of GSK to Present at GTCbio`s 3rd Assay Development and Screening Technologies Conference June 5-6
  • Hakim Djaballah, Director of HTS at Memorial Sloan Kettering Cancer Center to Present at GTCbio`s 3rd Assay Development and Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA
  • Clay Scott, Associate Director of Lead Generation at AstraZeneca to Present at GTCbio`s 3rd Assay Development and Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA
  • John Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline to Present at GTCbio`s 3rd Assay Development and Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA
  • Taosheng Chen, Director of HTS, St Jude Children`s Research Hospital to Present at GTCbio`s 3rd Assay Development and Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA
  • Xi Chen, Assistant Professor at University of California, Davis to Present at GTCbio`s 3rd Assay Development and Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA
  • Dr Didier Leroy, Team Leader of Lead Discovery Technologies at Merck-Serono to present at GTCbio`s 3rd Protein Kinase in Drug Discovery Conference on May 4-5, 2008 in San Diego, CA
  • AnaSpec Offers Fluo-3 - A High Affinity Fluorescent Calcium Indicator
  • Trevigen Launches LDEV Free Basement Membrane Extract
  • The PatchStar Micromanipulator from Scientifica
  • Top Italian medical device distributor NGC Medical signed the contract even before products were awarded CE Mark to ensure exclusivity Four new products will be exhibited at the EAU 2008 Conference in Milan
  • AnaSpec Introduces Suite of Labeled and Unlabeled Anti-Actin Antibodies
  • Automated Biotechnology Head at Merck and Co to give Keynote Presentation at GTCbio`s 3rd Assay Development and Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA
  • Robert Hertzberg, Vice President of Screening and Compound Profiling at GlaxoSmithKline to give Keynote Presentation at GTCbio`s 3rd Assay Development and Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA
  • GTCbio`s 3rd Assay Development and Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA
  • Jeremy Caldwell, Executive Director of Molecular and Cell Biology at the Genomics Institute of the Novartis Research Foundation to give the Featured Presentation at GTCbio`s 3rd Assay Development and Screening Technologies
  • Robert Hertzberg, Vice President of Screening and Compound Profiling at GlaxoSmithKline to give Keynote Presentation at GTCbio`s 3rd Assay Development and Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA
  • Berta Strulovici, Vice President of Basic Research MRL, and Automated Biotechnology Head at Merck and Co to give Keynote Presentation at GTCbio`s 3rd Assay Development and Screening Technologies Conference
  • Trevigen Launches Cultrex(r) 24 Well Cell Invasion Assay Kits
  • AnaSpec Introduces New Technical Support Solution
  • Dr Didier Leroy, Team Leader of Lead Discovery Technologies at Merck-Serono to present at GTCbio`s 3rd Protein Kinase in Drug Discovery Conference
  • Dr Susan Taylor, Professor of Pharmacology at UCSD to give Featured Presentation at GTCbio`s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA
  • Dr Karim Dabbagh, Director of Pharmacology at Roche to present at GTCbio`s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA
  • Senior Vice President of Regenerative Medicine at Geron to Present at GTCbio`s 4th International Stem Cell Research and Therapeutics, Apr 17-18, 2008 in Boston, MA
  • Samuel Wood, CEO at Stemagen, to give the Featured Presentation at GTCbio`s 4th International Stem Cell Research and Therapeutics, Apr 17-18, 2008 in Boston, MA
  • Pfizer to Present at GTCbio`s 4th International Stem Cell Research and Therapeutics, Apr 17-18, 2008 in Boston, MA
  • Jan Paul Medema, Professor of Experimental Oncology and Radiobiology at the Academic Medical Center of the University of Amsterdam to Present at GTCbio`s 4th International Stem Cell Research and Therapeutics, Apr 17-18, 2008
  • Senior Director at Genzyme to Present at GTCbio`s 4th International Stem Cell Research and Therapeutics, Apr 17-18, 2008 in Boston, MA
  • Malcolm Moos, Medical Officer of Division of Cellular and Gene Therapies at FDA to give Featured Presentation at the 4th International Stem Cell Research and Therapeutics, Apr 17-18, 2008 in Boston, MA
  • PMI announces its new Capillary Flow Porometer for Cartridge Media
  • AnaSpec Introduces Thirty-Eight New Catalog Peptides
  • MVNU reduces environmental and financial impact with biodiesel
  • Affiris Uses Definiens Technology in Fight Against Alzheimer`s Disease
  • Road Warriors Now Reaching Out to Mother Nature
  • PREMIER Biosoft International releases PrimerPlex, a tool for designing oligos for a multiplexed nucleic acid sequences for use with xMAP(r) based multiplex array systems
  • AnaSpec Introduces Phosphopeptide Standards Kit
  • AnaSpec Introduces 58 New Antibody Products
  • DENOVA NEUTRADERM Megalopolis Eye Mega Cream
  • BioSignia Launches Relationship with Bridges to Excellence(r) Through Know Your Number(r)
  • AnaSpec Introduces New SensoLyte(tm) Cathepsin D Activity Assay Kits
  • AnaSpec Introduces Ninety-Seven New Catalog Peptides
  • Trevigen Launches Anti-8-oxo-dG Monoclonal Antibody (Clone 2E2)
  • AnaSpec Introduces Two Novel Amino Acids
  • StemTech Cell Enhancers - Fact or Fiction
  • Invetech Opens New US Office to Support Expanding North American Client Base
  • AnaSpec Introduces Collection of Channel Blocker Peptides
  • Midbrook Inc Diversifies into Medical Cleaning and Decontamination
  • Trevigen Launches High-Throughput PARP Apoptosis Assays
  • California author announces the debut of new free writer`s web site
  • AnaSpec Introduces New Suite of Fluorescently Labeled GST and 6xHis Tag Antibodies
  • Planet`s Next Big Opportunity
  • BioMaxx Systems Inc renews European Federation of Biotechnology membership
  • ZYTO Corp Uses Editor Based LinksManager com to Generate Relevant Traffic and to Improve SEO
  • Stratlab is selling the Adams range of laboratory analytical balances
  • rPeptide Introduces Amyloid precursor proteins
  • AnaSpec Introduces Thirty-Six New Catalog Peptides
  • Former FDA Science Branch Director James Farley Joins InfoStrength as Advisor
  • RNCOS Releases Report on Booming Clinical Trials Market in India
  • Huntington Disease Foundation to Assess Six of Samaritan`s Drugs for Potential to Delay or Slow Progression of the Disease
  • SP-01A Provides HIV Patients Improved Quality of Life
  • AnaSpec Introduces 21 New Anti-Tau Antibodies
  • AnaSpec Introduces 9 New Antibody Products
  • AnaSpec Introduces Twenty-Five New Catalog Peptides
  • Cultrex(r) Antibodies to Basement Membrane Proteins
  • SPARKING GROWTH IN ONTARIO`S BIOPHARMACEUTICAL INDUSTRY
  • AnaSpec Introduces New Line of HABA-Biotin Quantitation Kits
  • ANAVEX outlines corporate milestones, drug advancement plans for 2008
  • AnaSpec Announces a Broad Selection of T-Cell Epitopes
  • Breath of Life Product In-Licensed to Samaritan Pharma
  • CEVEC again successful in challenge to Crucell patent
  • ARTES and Minapharm sign long-term strategic development agreement
  • AnaSpec Introduces New FRET Technology Brochure
  • Trevigen Launches Cultrex BME PathClear
  • Axium Awarded Phase III Clinical Trial Management Contract for OxThera`s Oxabact(tm)
  • AXIUM HEALTHCARE PHARMACY AWARDED PHASE III CLINICAL TRIAL MANAGEMENT CONTRACT FOR OXTHERA`S OXABACT(tm)
  • InfoStrength Launches New Life Science Website
  • AnaSpec Introduces Ten New Catalog Peptides
  • RNCOS Releases Report on Global Biometric Market
  • Premier Cord Blood Bank, LifebankUSATM, Reminds Clients to Take Advantage of their Exclusive, Limited-Time Holiday Offer
  • Evangelia Evdaimon starts third term with NCCSQA
  • AnaSpec Introduces First Colorimetric SensoLyte(tm) MMP Assay Kit
  • Anavex strengthens Board of Directors
  • RNCOS releases Report on Asia Pacific Biotechnology Market
  • ANAVEX advances drug candidates for treatment of epilepsy
  • ANAVEX 7-1037 demonstrates chemotherapeutic potential without toxic side effects for the treatment of colorectal cancer, other types of solid tumors
  • AnaSpec Introduces New Selection of Dye-Labeled Beta-Amyloid Peptides
  • InfoStrength and Clients enjoy win-win Relationship!
  • AnaSpec Introduces 10 New Catalog Antibodies
  • JT EATON INTRODUCES NEW SPRAY TO PREVENT TRANSPORT OF `UNWANTED GUESTS` IN LUGGAGE
  • AnaSpec Releases New Antibodies Brochure
  • Gain Back Lost Human Growth Hormone with GenF20(tm)HGH
  • GenF20(tm) HGH Pure Human Growth Hormone Releaser `Best Overall Health Tonic and Rejuvenator EVER`!
  • Biotechgate and Naturejobs Collaboration to Aid Recruiters and Jobseekers Globally
  • AnaSpec Introduces New Collection of Bcl Peptides
  • AnaSpec Introduces 17 New Anti-Tau Antibodies
  • PREMIER Biosoft International joins Microsoft in the BioIT Alliance
  • AnaSpec Celebrates the Holidays with Its Customers
  • AnaSpec Introduces AnaTag(tm) Protein Labeling Kits with HiLytePlus(tm)
  • GVK BIO raises Rs100 crores from Sequoia Capital
  • BioInformant launches Digital Protection Services to protect website content and ensure competitors are not using trademarks, products or brand names to misdirect online business
  • Laser Guidance Takes a Quantum Leap
  • ZYTO Corporation Announces Engagement of RedChip Companies to Lead Investor Relations
  • Los Angeles Health and Wellness Clinic Uses Biotechnology to Make Alternative Health Care Decisions
  • Cotati Alternative Health Care Professional Uses Biotechnology to Make Health Care Decisions
  • Lexington Chiropractor Uses `Star Trek` Technology for Alternative Health Care and Wellness
  • Madill Chiropractor Announces Addition of ZYTO Biotechnology to Improve Health Care Services
  • Mesa Naturopathic Physician Uses Biotechnology to Make Alternative Health Care Decisions
  • AnaSpec introduces HiLytePlus(tm) Labeled Secondary Antibodies and Streptavidin
  • DRE Announces Launch of Enhanced Medical Equipment Website
  • BioInformant Partners with Research Product Companies to Target Prospects with Responsive Email Lists
  • BioInformant Launches Product Citation Tracking and Database Management for Research Product Companies
  • AnaSpec Introduces Thirteen New Catalog Peptides
  • AnaSpec Introduces HiLytePlus(tm) - AnaSpec`s Highest Performance Fluorescent Dyes
  • Eufaula Naturopathic Doctor Uses Biotechnology to Make Alternative Health Care Decisions
  • Riverside Private Health Spa Uses Biotechnology to Make Alternative Health Care Decisions
  • Alexandria Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • Farmington Health Care Clinic Uses Biotechnology to Make Alternative Health Care Decisions
  • Sapulpa Chiropractor Alternative Health Pain Clinic Uses Star Trek Technology for Health and Wellness
  • American Fork Chiropractor Uses Biotechnology to Decide on Alternative Health Care Solutions
  • South Surrey Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • SciMercor,LLC Launches as Scientific Equipment Sourcing Service - Specializing in Overseas Facilities
  • Transinsight wins futureSAX VC-Forum for best company
  • Clinical trials in computer
  • First Indian vaccine manufacturer to successfully produce Revac-Bmcf, a thimerosal-free Hepatitis B Vaccine
  • Bioinformatics Institute of India introduces an Informative Directory of Clinical Trials
  • Bioinformatics - New Potion for Biotech and Pharma Firms, says RNCOS
  • InfoStrength(r) Hires James Comito Software Developer
  • Sector Close Up - Pharmaceutical and Biotech Stocks - Is Gene Therapy the Next Major Breakthrough in Cancer Treatment
  • The DANI MASTER Gas Chromatograph will speed up your productivity and improve your precision
  • BioMinds LifeSciences announces the release of PathoOligoDB(TM), a free data bank of validated qPCR oligos and related resources for pathogen detection
  • The US biotech market has been experiencing diverse changes for the past few years, but despite these changes, it is only booming
  • High tech `Bond` style technology reaches Dorset homes
  • FEECO International to Exhibit at the 2007 International Distillers Grain Conference
  • Indian Biotechnology Market Outlook (2006)
  • Dr David Kaslow, Vice President of Infectious Diseases and Vaccines at Merck to give Keynote presentation at 3rd Modern Drug Discovery and Development Summit
  • AnaSpec Introduces Labeled RGD Peptide for In Vivo Imaging
  • AnaSpec Introduces One New Amino Acid and Two New Catalog Peptides
  • Medical Device company uses InfoStrength for due diligence
  • METABOLIC DISEASE HAS A GREATER EFFECT ON THE HEALTH OF OUR SOCIETY THAN CANCER
  • GTCbio`s 5th International Conference on Vaccines - All Things Considered
  • The New Avegene ePipette Electronic Pipettor Family
  • AnaSpec Launches New SensoLyteTM Caspase-8 Assay Kit
  • SVP and Site Head of Pfizer La Jolla to Give Plenary Keynote Address at 3rd Modern Drug Discovery and Development Summit
  • AnaSpec Introduces Improved Website Search Tool
  • AnaSpec Introduces Anti-Keratin-18 and 19 Antibodies
  • AnaSpec Introduces Fifteen New Catalog Peptides
  • South Surrey Kinesiologist Adds Bio-technology to Improve Alternative Healthcare Services
  • Wilmington Chiropractor Adds ZYTO Biotechnology to Improve Patient Services
  • Hamilton Square Acupuncturist Uses Star Trek Technology for Health and Wellness
  • Fort Collins Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • Eaton Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • Denver Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • AnaSpec Introduces Series of Dye-Labeled Amino Acids and Resins
  • FEECO International Featured in US Industry Today Magazine
  • Brookfield Alternative Healthcare Announces Free Demo of ZYTO Technology
  • Columbia Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • Sapulpa Chiropractor Adds ZYTO Biotechnology to Improve Health and Wellness Services
  • Los Angeles Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • Kalispell Chiropractor Adds ZYTO Biotechnology to Improve Patient Services
  • Cotati Alternative Healthcare Uses Star Trek Technology for Health and Wellness
  • El Dorado Hills Chiropractor Adds ZYTO Biotechnology to Improve Chiropractic Healthcare
  • Creative Technology Services Joins Forces with CJPS Enterprises
  • AnaSpec Introduces Nine New Catalog Antibodies
  • ZYTO Corp Provides Biotechnology to Health and Nutrition Business in China
  • DNA Solutions
  • Definiens Receives Frost and Sullivan Award for Technology Leadership in the High Content Screening Market
  • DNA key to save Cambodian elephants
  • AnaSpec Introduces Thirty-Two New Catalog Peptides
  • PREMIER Biosoft International announces the release of a free edition of Beacon Designer
  • Cisbio and Lumiphore Announce Partnership for New Product and Technology Development Incorporating Lumi4(tm) Compounds
  • AnaSpec Introduces Fifty-Five New Catalog Peptides
  • AnaSpec`s Published References Passes 500
  • AnaSpec Introduces 10 New Catalog Antibodies
  • AnaSpec Introduces Industry`s Longest Wavelength Assay Kit for TACE Detection
  • AnaSpec Introduces CEF Control Peptide Pool
  • AnaSpec Introduces 28 New Catalog Antibodies
  • AnaSpec Introduces New 2007-2009 Combinatorial Chemistry Catalog
  • New Non-Contact Microarrayer Replaces Pen Spotting
  • BiotechCrossing Offers an Exclusive Free 30-Day Trial Subscription
  • Live Blood Labs Microscopes provide the most innovative blood analysis methods for better blood analysis
  • Forensic Microscopes provide the best tools in forensic analysis, comparison, and detection
  • Projection microscopes com brings projection microscope technology to the field of study
  • Teaching Microscopes com answers all microscopy needs in the field of teaching
  • Microscopes from Tissue Culture Microscopescom produce the clearest, most detailed images to be studied in the field of living tissue research
  • Low Power Microscopes showcases the biggest array of stereo microscopes ever to be sold online
  • Microscopic images now seen in better and clarity and greater detail through Phase Contrast microscopy
  • Ore Microscopes brings microscopy equipment to provide the best tools for precision measurement and analysis of rocks and minerals
  • Toolmakers Microscopes announces the solution to microscopic measuring needs and minute detail analysis
  • PREMIER Biosoft Releases Version 5 of AlleleID with MLPA support
  • USB Microscopes launches USB Microscopes com, the best source of quality microscopes with USB connectivity
  • ENT Microscopes com provides the best quality microscopes for medical and dental surgery applications
  • Epi-Flourescence Microscopes is now the ultimate source for all fluorescence microscopy needs
  • Metallurgical Microscopes announces its website is the one-stop shop for all metallographic and epi-illumination microscopy needs
  • Polarizing Microscopes com offers better images through Cross Polarization lighting system
  • PREMIER Biosoft Releases Version 7 of Beacon Designer with Support for Scorpions(r) assays
  • Adult stem cells better choice than death or transplant for heart failure patients
  • Analytical Results Highlight Efficacy of AnaSpec MOG Peptides
  • AnaSpec Introduces Acetylated and Methylated Lysines
  • Adult stem cells take New York woman from death`s door to dance floor
  • AnaSpec Introduces Fourteen New Catalog Peptides
  • AnaSpec Introduces 12 New Catalog Antibodies
  • 114 Blockbuster Drugs Accounted for 2006 Sales of US$ 233,7 bln
  • AnaSpec Introduces Ten New Catalog Peptides
  • India`s Biotechnology Industry Blooming
  • Definiens Reveals an Integrated Data Management Approach For Image Analysis in Life Sciences Enterprises
  • AnaSpec Introduces New Selection of Cathelicidin Peptides
  • AnaSpec Introduces Anti-MMP-1 and Anti-MMP-13 (Hinge) Antibodies
  • Biotech leader lifts lid on $100 billion stem cell scam
  • American Peptide Symposium Poster Describes Synthesis of Hydrocarbon-Stapled Peptides
  • AnaSpec Presents Late-Breaking In Vivo Imaging Poster at American Peptide Symposium
  • India - Biotech Industry Hit US$ 2 Billion Mark in 2006-07
  • Biodiesel Production Equipment
  • Aesis Research Group debuts the Life Sciences Business and Investment Daily featuring incisive commentary by thought leader Dr Ogan Gurel and others
  • Biotechnology - Planet`s Next Big Opportunity
  • AnaSpec Introduces New Anti-MOG (35-55) Antibody
  • PharmaChem Publishes AnaSpec Article on Peptides as Antigens
  • OSI Pharmaceuticals to Present on Enabling Technologies for Oncology Biomarker Discovery at GTCbio`s Rediscovering Biomarkers Detection, Development and Validation Conference (July 23-24, 2007, San Diego, CA)
  • AnaSpec Introduces New SensoLyte(tm) Beta-Secretase Assay Kit
  • BioAnalyte supports FDA Intact Protein Expression (IPEx) Mass Spectrometry Approaches for Label-free Relative Quantitation and Biomarker Discovery
  • AnaSpec Introduces Industry`s First and Only Anti-MOG ELISA Kits
  • Biosyn Press Releases
  • Human LDH Isoenzymes Available from Lee Biosolutions
  • E coli, salmonella, mold, mildew, staph virus virtually eliminated by Lumilife Systems(tm)
  • AnaSpec Prepares Technical Poster about Beta-Secretase Assay for Experimental Biology 2007
  • Veeda Clinical Research Strengthens its Global Operations to Work as Single Global Brand
  • ENLASO (translate com) Creates Dedicated `Into-English` Translation and Localization Department
  • The imminent change of the antithrombotics market
  • Biotechnology Stock News - Natural Anti Inflammatory Biotechnology Pharmaceuticals Developer Acquires Marketing Company And Multiple Proprietary Technologies
  • Novel Agent for Reactive Metabolite Detection
  • Brothers jump out of the hearse and onto the golf course thanks to adult stem cells
  • Bio-Pharmaceuticals Driving Pharma and Biotech Sectors in India
  • AnaSpec Introduces Line of Insulin Receptor Antibodies
  • AnaSpec Introduces Thirteen New Catalog Peptides
  • DENOVA Royal Hydra Balance SQ9 DENOVA presents its new 2007 line Royal Hydra Balance SQ9 for dry and oily skin!
  • C-Reactive Protein Available to Researchers from Lee Biosolutions
  • FEECO International Releases Innovative Ethanol Site
  • Industry`s First West Nile Virus Protease Assay Kits
  • ZYTO Corp Annual Meeting of Stockholders Elects Board of Directors Following Biotechnology Conference
  • US Biotechnology Firms Grew Exponentially in 2006
  • Virginia Based Software Development Company Sponsors Annual Triangle Event
  • First Commercially Available Beta-Amyloid Peptides (1-44 to 1-48)
  • Human Hemoglobin now Available to Researchers from Lee Biosolutions
  • ENLASO (translate com) to Host Webinar on Taking Life Science Products to the International Market
  • Fortitech Mexico Announces Strategic Business Relocation
  • The Van Andel Research Institute and Emiliem Sign Major Translational Medicine and Biomarker Agreement
  • Malaysia Endeavors to Outsource Biotech Services from US
  • Beyond biogenerics - the real threats for therapeutic proteins
  • Protein Kinases Catalyze Phosphorylation of Other Proteins
  • Venture Valuation and BIOTECanada launch new online database of Canadian life sciences companies (www canadianlifesciences com)
  • Synamatix Announces Release of Bioinformatics Solutions for Second Generation Sequencers
  • GTCbio Announces 2007 Fellowship Awards and Charitable Donation
  • Human Alpha-1 Antitrypsin Antigen now Available to Researchers from Lee Biosolutions
  • Stem Cell Study - Future of Cardiovascular Research
  • Zyto Corp Announces Additional Presenter at Biotechnology Conference for Healthcare Practitioners
  • Interleukin and Chemokine Antibodies - Two Types of Cytokine Antibodies
  • AnaSpec Introduces 69 New Antibodies
  • ABRF Poster Presents Comparison of Fluorescent Peptide Synthesis Methods
  • Soaring Demand for Ethanol Spikes Corn Prices in US
  • Simplified TCR clonality assay kits for vaccine development and immunology research
  • Salivary Amylase Enzyme EC NO 3 2 1 1 from Human Saliva now Available to Researchers from Lee Biosolutions
  • AnaSpec Introduces 51 New Apoptosis-Related Antibodies
  • New Dye Solution for Far Red to NIR Imaging
  • Indian Stem Cell Market to Hit US$ 540 Million by 2010
  • Zyto Corp Announces Annual Conference for Healthcare Practitioners
  • Low Price DNA Polymerase AmpSure Taq from WISBiomed
  • D-dimer Antigen now Available to Researchers from Lee Biosolutions
  • AnaSpec Introduces AnaTag(tm) Protein Labeling Kits
  • AnaSpec Launches Optimized Website
  • India Leads Asian Biotech Sector
  • CTL Announces Validation of Reference Samples for use in Regulated Human, Pig, and Mouse ELISPOT Assays
  • Multi-Platform Technology Provides Ideal Base for Labeled Secondary Antibodies
  • High-Performance Spacer for Peptide Labeling
  • AnaSpec Introduces 82 New Antibodies
  • Rising Ethanol Demand can push Food Prices Higher
  • Very Low Density Lipoprotein (VLDL) Available to Researchers from Lee Biosolutions
  • Bio3 Research Srl, Milan -Italy,has been granted by the Australian Patent Office in the field of cardiovascular diseases related to HMGB1 over-expression and for the use of HMGB1 protein in connective tissue regeneration
  • Name Change - AnaSpec`s EnzoLyte is now SensoLyte(tm)
  • BioLED Lab on a Chip Technology Successfully Demonstrated
  • New Additions to AnaSpec`s SensoLyte(tm) MMP Product Line
  • TCRexpress Clone Screening Kit For T cell clone available from WISBiomed
  • Creabilis therapeutics SpA appoints Domenico Criscuolo as Chief Medical Officer
  • The new class of dipeptidyl peptidase IV (DPP-IV) inhibitors has one clear leader and many followers
  • Teen Author, Asad Moten, Aims to Provide the Answer to Several Medical Mysteries
  • TOP Classes of Biologics with 2006 Sales of US$ 63 8 bln
  • Automated internal perfusion with the Port-a-Patch
  • AnaSpec Makes In-House Fmoc and Boc Amino Acids Available to Public
  • VeriTask Software demonstrates Biometric Employee Time Clock(tm) at Texas Association of Staffing trade show
  • PREMIER Biosoft and PamGene International BV form an alliance
  • Genfit extends its drug discovery strategic alliances with Sanofi-Aventis and Solvay
  • Novexin`s sales boosted by InstantBlue gel stain
  • The market of recombinant coagulation factors is growing with next generation products
  • Small Businesses Get A New Release From The Audio Book Guide With `The E Myth Revisited` by Michael E Gerber
  • AnaSpec Introduces One of the World`s First Collections of Synthetic Phytochelatin Peptides
  • AnaSpec Introduces Fifty-Five New Catalog Peptides
  • Nestle licenses Novel Heart Disease product to Cambridge Theranostics
  • Overview On 2006 Sales Of TOP 20 Biologics To
  • Aurigene and Merck Serono enter a Discovery Collaboration to identify therapeutics for Autoimmune Disorders
  • Aurigene and Forest Laboratories to collaborate on Development of Novel Oral Therapeutics for Obesity and Metabolic Disorders
  • AnaSpec Makes In-House Line of Peptide Synthesis Accessories Available to Public
  • BioAsk offers Research Intelligence and Trend Analysis for free!
  • AnaSpec Key Supplier for Significant Study on pGlu Modified Beta-Amyloid Peptides
  • Expert Panel to Discuss the Progress of Project Bioshield
  • PREMIER Biosoft International Releases TMA Foresight, a Statistical Tool for Tissue Microarray Data Analysis
  • AnaSpec Introduces Suite of Rigorously Validated SOCS Antibodies
  • The right balance drives the field of PPAR agonist RandD
  • Biotech leader lashes media `lies` about stem cells
  • Odds favor Hawaiian`s return to health with stem cell therapy
  • Death sentence for Australian commuted by stem cells
  • `BioAsia 2007 Thailand` expects to attract over 15,000 visitors worldwide
  • Finnzymes Instruments releases a new line of PCR thermal cyclers and ultra-thin wall plastics
  • AnaSpec to Sell Classic Fluorescence Textbook
  • ASCB Poster Presents Immunocapture Techniques for Improved MMP Assay
  • Fluorinated Building Blocks Produce Molecules with Enhanced Physiological Activities
  • AnaSpec Introduces Line of Assay Kits for Phosphatase Detection
  • Ghrelin and Obestatin Peptides Linked to Appetite
  • SHANTHA - MERIEUX ALLIANCE TO INVEST IN STATE OF THE ART SUITE FOR ADVANCED VACCINE PRODUCTION
  • AgroMicron Adds Environmental Trade Division
  • Website reports on `super-secret` bionics industry
  • Published References to AnaSpec Products Surpasses 400
  • Earth Alive Resources Introduces All-Natural RapidAll Cleaning Solution
  • Thailand PM to open international symposium in Bangkok on stem cell therapy for the failing heart
  • TheraVitae Presents Positive Stem Cell Trial Results at American Heart Association Convention
  • Melanoma Epitopes Used in Studying Tumor Regression
  • ErbB2 (Her-2) and p53 - Important Antibodies for Cancer Research
  • Drug Delivery Research Leads to Non-invasive Treatments for Major Diseases
  • TRACON PHARMACEUTICALS, INC ANNOUNCES PRESENTATION AT RODMAN and RENSHAW 8TH ANNUAL HEALTHCARE CONFERENCE
  • BioAsia 2007 to Take Off in Thailand in November 2007
  • AnaSpec Introduces Improved MMP Detection Solutions
  • AnaSpec Introduces `Search by Research Topic` Functionality
  • PREMIER Biosoft and MRC-Holland form an alliance
  • Gentris Corporation Announces FDA 510(k) Submission for GentriSure Human Genomic DNA Reference Controls for CYP2D6 Gene
  • AnaSpec Expands Facilities for Antibodies and Assay Kits
  • Coelenterazine and Its Analogs Provide Major Advantages for Luminescent Calcium Detection
  • BiotechIndustryStocks com - Biotechnology Investor Portal Updates and Expands Directory of Biotechnology Stocks
  • Homo-Amino Acids Provide Novel Options for Drug Discovery
  • PREMIER Biosoft International Releases SimGlycan, An Innovative Glycan Mass Fingerprinting Tool
  • US Ethanol Production and Demand reach all time Highs
  • GenoSensor Signs Deal with BioCat
  • Calcium Homeostasis and the Roles of PTH and Calcitonin Peptides
  • The AEgis Technologies Group Announces the Release of acslXtreme Version 2 3
  • NARVALUS Srl IS PLEASED TO ANNOUNCE THE LAUNCH OF THE `T2 TARGET TRANSFECTOR`
  • Swiss venture capitalists explore bionics industry
  • Delivery improvements of the AMD-drug Lucentis on the way
  • GENFIT INITATES PHASE I CLINICAL TRIALS OF GFT505, A MULTIMODAL MOLECULE DEDICATED TO THE PREVENTION AND TREATMENT OF SEVERAL RISK FACTORS OF CARDIOMETABOLIC DISEASE
  • AnaSpec Synthesizes MOG Peptides for MS Research
  • AnaSpec Introduces HTS-Optimized EnzoLyte Caspase Assay Kits
  • Biologics define new standard of therapy in psoriasis
  • AnaSpec Introduces Extensive Line of Caspase Substrates and Inhibitors
  • PREMIER Biosoft Releases Version 6 of Beacon Designer with Support for MethyLight assays
  • China Gets A Spurt Of New Energy
  • Dr Rich Meyer Joins AnaSpec to Lead Detection Reagents Division - Strengthens AnaSpec`s Product Applications Expertise
  • Biopharmaceuticals - A Jewel In The Crown
  • The Crowded Field of VEGF and VEGF-R Targeting Drugs
  • AnaSpec Presents One of the World`s Most Comprehensive Collections of Amyloid Peptides
  • AnaSpec Offers Vital Stains for Amyloid Imaging
  • Potentia Pharmaceuticals Licenses Complement Inhibitor from the University of Pennsylvania
  • AnaSpec Releases 2006-2008 Peptides Catalog
  • AnaSpec Introduces New Line of Secretase Research Solutions
  • A Full Pipeline of Follow-on TNF-Antagonists
  • Genomics Creates Opportunities in Drug Discovery Market
  • HCV Proteases - Wild-Type and Mutated
  • Bio Balance`s Website for Receptor Activation
  • Biotech, Drug Actives, Pharmaceuticals Knowledge Center
  • Biogenerics and new technologies compete with 1st generation major protein products
  • Imminent launches of new EPO products and consolidation of the biogenerics field
  • Localized delivery of PDE-4 inhibitors to open the therapeutic window
  • Licensing Agreement signed between HyperOmics Farma Inc and the Biotechnology Research Institute (NRC)
  • Technical and RandD Investments Reinforce Fortitech Europe`s Growth Objectives
  • The next generation of interferons needs improvement in efficacy and safety
  • Indian Biotech Industry Successful IT cousin
  • LC Sciences Keeps Pace with Sanger miRBase microRNA Sequence Updates
  • RNA interference (RNAi) is coming of age as a therapeutic modality
  • RNCOS Research The Budding India`s Biotech Hub Hyderabad
  • Mondial Translations and Interpreting Launches Referral Program
  • RNCOS Research - The Budding India`s Biotech Hub Hyderabad
  • GENFIT initiates Phase II clinical trials with GFT14
  • Biotechnology Investor Portal, Adds To Online Content
  • RNCOS Research - Indian Biotech Industry Successful IT cousin
  • HEALTHCARE ROYALTY FREE IMAGES AVAILABLE `Royalty Free Medical` Image Collection Available at cmsp com
  • Gentris Announces UGT1A1 Sub-Licensing Agreement
  • RNCOS Research India`s Desire - World`s Future Source for Biotech Appetite
  • Biomaxx Systems Inc joins European Federation of Biotechnology
  • RNCOS Research - India Biotech Disappointed- Not Enough Tax Incentives
  • RNCOS Research - India`s Desire - World`s Future Source for Biotech Appetite
  • Gentris Corporation Introduces Human Genomic DNA Reference Controls for CYP2D6 Gene
  • SciMercor Launches Health Science Equipment and Supplies Auction Site
  • Global Demand Supports Development of Avian Flu Treatments and Antiviral Drugs
  • Zangani Investor Community Announces Interview with ViRexx Medical Corporation President Marc Canton
  • Animal cloning coming soon
  • Biophan and Siemens AG Announce a Declaration of Intent for Strategic Collaboration on Advanced Interventional MRI Technology
  • Bio3 Research and Daxley Group Enter into License Agreement for Biocysan in End-Stage Renal Disease
  • Bio3 Research and Daxley Group Enter into License Agreement for Biocysan in End-Stage Renal Disease
  • Bio Balance`s Most Informative Website for Receptor Activation
  • On-line Messung von Produkteigenschaften und suspendierten Feststoffen - Messung der Produkt-Trennung
  • On-line measurement of product properties and suspended solids - measurement of the product separation
  • The irresistible sirene`s chant of needle-free insulins
  • Elite Recruiting Services, Inc and Elite Staffing Services, Inc to Host Biotechnology Job Fair Luncheon
  • Antibodies are the first wave of IGF-1R antagonists for cancer therapy
  • Lokmangal Biofertilizers
  • Cornerstone BioPharma, Inc and ASCEND Therapeutics Sign Co-Promotion Agreement
  • Amptronix Inc Debuts its Biometric Product Line
  • Dawn has broken for obesity treatment with cannabinoid receptor (CB1) antagonists
  • TOP 20 Biologics now with sales of US$ 37;7 bln in 2005
  • Professor Marco Bianchi and Creabilis Therapeutics announce the creation of HMGBiotech Srl
  • wwwtransadvanciscom is in and starts its operations
  • Dosing convenience mandates the pipeline of glucagon-like peptide-1 (GLP-1) analogs for type 2 diabetes
  • BioAxxis(R) Brand Continues Expansion for Axxis Biometrics
  • Emerging diabetes drugs in early development
  • CAS Announces New Featured Company Bridgetech Holdings International Inc
  • High interest in inhibitors of the novel target sodium-dependent glucose (co-) transporter (SGLT) for therapy of type 2 diabetes
  • Tight race to be the first in a new class of dipeptidyl peptidase IV (DPP-IV) inhibitors for the oral treatment of type 2 diabetes
  • Bioluminescence Detection Program by AgroMicron
  • Gentris Announces Promotion and Strategic New Hire
  • Gentris Joins Personalized Medicine Coalition
  • Bio3 Research and Creabilis Therapeutics Sign Research Agreements with Cephalon, Inc
  • Cardiovascular safety determines the direction of PPAR agonist R and D
  • Acrongenomics, Inc. Retains KGMC Group, LLC
  • Competition is needed in the follicle stimulating hormone market
  • Thrombolytic therapy needs innovation
  • New Generation Drug Discovery Software Enters Market
  • A biogeneric company leads the field of next generation human growth hormone (hGH)
  • Too many companies with biogeneric G-CSF products compete for a small market
  • Gentris Corporation Announces Live Webcast
  • SiliconValleyNano.com Nanotech Website Chooses Phaze-9 to Promote Awareness of the Industry
  • CDC and FDA to Discuss Vaccine Stockpiles and Pandemic Influenza Preparedness at Annual Vaccines Conference
  • Scientists Come Together to Discover Possible Cures for Neurodegenerative Diseases
  • Robert A. Weinberg to Deliver a Keynote Address at GTCbio’s 2nd International Conference on Tumor Progression & Therapeutic Resistance
  • New RSS Feeds Feature from BiotechConnection.com
  • RealEngineer.com appoints Mark Singh as New Senior Technical Editor
  • MorphoSys Reports Six Months 2005 Results
  • High-Resolution Brain Atlases in CyberSpace
  • Covance to Present at the FBR 9th Annual Growth Investor Conference
  • Covance Files Lawsuit Against PETA and Its Infiltrator
  • Enzyme Patents RSS Feed
  • ‘Consumable’ Software License Hits the Bioinformatics Street
  • Chimeracom Receives Patent for Heretofore Unknown Family of Analgesic Drugs
  • MD Biosciences and Becton Dickinson sign Agreement For the Distribution of Streptococcus Cell Wall Extract, PG-PS
  • Open Source Expert Joins BioAnalyte
  • Food supplements for a hungry market
  • C. Thomas McMillen Joins the Board of Advisors of BioDefence Corporation
  • SUPPLY NEW BIO-CHEM PHARMACEUTICAL PRODUCTS
  • Reagents-and-Buffers.com (Boston Bioproducts Inc) successfully climbs the ladder in Research Industry

    •  

    More Biotech News on EPRBiotechNews.com

     

     

     

    		 

    Untitled Document

     

    Submit Press Release (Free)Submit Press Release

     

    Press Release ForumPress Release Forum

     

    Press Release BlogPress Release Blog

     

     

     

     

     

    About | Submit Press Release | Help | Search | Links | Nationwide / EPR Network

    © 2004-2009 Express-Press-Release.Net. Part of EPR-Network.com. All Rights Reserved. All trade marks and names are owned by their respective owners
    Link to Us / Privacy / Disclaimer / Feedback -- Questions, Suggestions, Comments at E-mail: info@EPR-Network.com
    EPR disclaims any content found in press releases -- full disclaimer can be found here

    Contextually linked in LinkedWords

     
    		 
    Express Press Release Distribution